Cleared Special

K030615 - INFINITY EXPLORER

K030615 is the FDA 510(k) clearance for INFINITY EXPLORER by Siemens Medical Solutions USA, Inc.. It is a Class 2 Cardiovascular device (product code MSX) cleared through the Special 510(k) pathway after a 23-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2003
Decision
23d
Days
Class 2
Risk

K030615 is an FDA 510(k) clearance for the INFINITY EXPLORER. Classified as System, Network And Communication, Physiological Monitors (product code MSX), Class II - Special Controls.

Submitted by Siemens Medical Solutions USA, Inc. (Danvers, US). The FDA issued a Cleared decision on March 21, 2003 after a review of 23 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Siemens Medical Solutions USA, Inc. devices

Submission Details

510(k) Number K030615 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 26, 2003
Decision Date March 21, 2003
Days to Decision 23 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
102d faster than avg
Panel avg: 125d · This submission: 23d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code MSX System, Network And Communication, Physiological Monitors
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MSX System, Network And Communication, Physiological Monitors

All 72
Devices cleared under the same product code (MSX) and FDA review panel - the closest regulatory comparables to K030615.
DATEX OHMEDA S/5 WEB VIEWER AND S/5 POCKET VIEWER WITH L-WEB03 SOFTWARE
K033078 · Datex-Ohmeda · Oct 2003
UNITY NETWORK PATIENT DATA SERVER
K032582 · Ge Medical Systems Information Technologies · Sep 2003
UNITY NETWORK IS PATIENT VIEWER
K032346 · Ge Medical Systems Information Technologies · Aug 2003
DATEX-OHMEDA S/5 WEB VIEWER WITH L-6WV02 SOFTWARE
K023497 · Datex-Ohmeda · Nov 2002
DATEX-OHMEDA S/5 NETWORK AND CENTRAL '02
K022507 · Datex-Ohmeda · Aug 2002
UNITY IS PATIENT VIEWER
K020661 · General Electric Medical Systems Information Techn · May 2002